The pegylated arginine deiminase degrades arginine, creating arginine deficiency in ASS1-deficient cells and thereby inhibiting cancer cell growth, as demonstrated in melanoma and hepatocellular carcinoma cells in vitro [11]. Here, ASS1 is linked to cancer.